4-88468404-G-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_016323.4(HERC5):āc.1116G>Cā(p.Leu372Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000209 in 1,610,430 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_016323.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
HERC5 | NM_016323.4 | c.1116G>C | p.Leu372Phe | missense_variant | 8/23 | ENST00000264350.8 | |
HERC5 | XM_011532022.3 | c.1116G>C | p.Leu372Phe | missense_variant | 8/21 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
HERC5 | ENST00000264350.8 | c.1116G>C | p.Leu372Phe | missense_variant | 8/23 | 1 | NM_016323.4 | P1 | |
HERC5 | ENST00000508159.1 | c.30G>C | p.Leu10Phe | missense_variant | 2/17 | 2 |
Frequencies
GnomAD3 genomes AF: 0.000197 AC: 30AN: 152172Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000445 AC: 111AN: 249628Hom.: 0 AF XY: 0.000445 AC XY: 60AN XY: 134960
GnomAD4 exome AF: 0.000211 AC: 307AN: 1458140Hom.: 0 Cov.: 28 AF XY: 0.000212 AC XY: 154AN XY: 725512
GnomAD4 genome AF: 0.000197 AC: 30AN: 152290Hom.: 0 Cov.: 32 AF XY: 0.000121 AC XY: 9AN XY: 74454
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 16, 2023 | The c.1116G>C (p.L372F) alteration is located in exon 8 (coding exon 8) of the HERC5 gene. This alteration results from a G to C substitution at nucleotide position 1116, causing the leucine (L) at amino acid position 372 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at